Breadcrumb Home / Investors & Media / node Explore Investors & Media Explore Investors & Media Investor Overview Press Releases Archived Press Releases Events & Presentations Corporate Governance Committee Composition Management Team Board of Directors Financials & Filings SEC Filings Stock Information Historical Stock Lookup Investment Calculator Analyst Coverage Investor FAQs Contact IR or Media Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability Read more about Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability Scholar Rock to Participate in Upcoming Investor Conferences Read more about Scholar Rock to Participate in Upcoming Investor Conferences Scholar Rock to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023 Read more about Scholar Rock to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023 Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting Read more about Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting Scholar Rock Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares Read more about Scholar Rock Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares Scholar Rock Announces Pricing of Upsized Public Offering of Common Stock Read more about Scholar Rock Announces Pricing of Upsized Public Offering of Common Stock Scholar Rock Announces Proposed Public Offering of Common Stock Read more about Scholar Rock Announces Proposed Public Offering of Common Stock Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders Read more about Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial Read more about Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Read more about Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Subscribe to RSS Feeds Search
Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability Read more about Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability
Scholar Rock to Participate in Upcoming Investor Conferences Read more about Scholar Rock to Participate in Upcoming Investor Conferences
Scholar Rock to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023 Read more about Scholar Rock to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023
Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting Read more about Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting
Scholar Rock Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares Read more about Scholar Rock Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
Scholar Rock Announces Pricing of Upsized Public Offering of Common Stock Read more about Scholar Rock Announces Pricing of Upsized Public Offering of Common Stock
Scholar Rock Announces Proposed Public Offering of Common Stock Read more about Scholar Rock Announces Proposed Public Offering of Common Stock
Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders Read more about Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders
Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial Read more about Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Read more about Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)